Adagene

About:

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

Website: http://www.adagene.com/

Top Investors: General Atlantic, F-Prime Capital, HongShan, Eight Roads Ventures, Gopher Asset Management

Description:

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.

Total Funding Amount:

$155M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2011-01-01

Contact Email:

info(AT)adagene.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2021-02-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai